These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18428083)

  • 1. Genomics in drug discovery: the best things come to those who wait.
    Bansal AT; Barnes MR
    Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNAs in drug discovery: target validation and beyond.
    Natt F
    Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides for target validation and gene function determination.
    Taylor MF
    IDrugs; 1999 Aug; 2(8):777-81. PubMed ID: 16127653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional peptides by genome reverse engineering.
    Grigorov MG; van Bladeren PJ
    Curr Opin Drug Discov Devel; 2007 May; 10(3):341-6. PubMed ID: 17554861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic approaches to drug discovery.
    Ricke DO; Wang S; Cai R; Cohen D
    Curr Opin Chem Biol; 2006 Aug; 10(4):303-8. PubMed ID: 16822705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primer: genomic and proteomic tools for the molecular dissection of disease.
    Walker EJ; Siminovitch KA
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.
    Hardy LW; Peet NP
    Drug Discov Today; 2004 Feb; 9(3):117-26. PubMed ID: 14960389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for target identification and validation.
    Wang S; Sim TB; Kim YS; Chang YT
    Curr Opin Chem Biol; 2004 Aug; 8(4):371-7. PubMed ID: 15288246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increasing importance of genetic variation in drug discovery and development.
    Labaudinière R
    Curr Opin Mol Ther; 2002 Dec; 4(6):559-64. PubMed ID: 12596357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of genetic association studies in identifying new drug targets.
    Lowe JA; Jones P; Wilson DM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):603-5. PubMed ID: 18729011
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic filtering: an approach to discovering novel antiparasitics.
    McCarter JP
    Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug discovery based on genomic information].
    Nohmi T
    Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput target discovery using cell-based genetics.
    Jackson PD; Harrington JJ
    Drug Discov Today; 2005 Jan; 10(1):53-60. PubMed ID: 15676299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional genomics in hypertension.
    McBride MW; Graham D; Delles C; Dominiczak AF
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):145-51. PubMed ID: 16481881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug discovery based on genome sciences and rational drug design].
    Itai A
    Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2630-4. PubMed ID: 11802442
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data-rich landscape.
    Michelson S; Joho K
    Curr Opin Mol Ther; 2000 Dec; 2(6):651-4. PubMed ID: 11249742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.